22

COMPANIES SOLD

$1

BILLION+ RAISED

30+

YEARS EXPERIENCE
Cannabis consolidation is accelerating, but Seth Yakatan doesn’t see all M&A strategies as equal. The veteran dealmaker and cannabis industry advisor sees two executives making particularly aggressive moves: Curaleaf Executive Chairman Boris Jordan and Vireo Growth CEO John Mazarakis.
The cannabis industry does not have a capital problem in the way many operators like to describe it. Capital still exists. Debt remains available to qualified operators, lenders continue to evaluate deals, and investors have not abandoned the space.
Cannabis stocks have rebounded sharply over the last twelve months. The AdvisorShares Pure US Cannabis ETF, MSOS, has climbed roughly 104% year-over-year, while the S&P 500 is up about 28% over the same period. On the surface, the sector appears to be recovering.
Become an Insider

You’ll get first dibs on events, podcasts, webinars, giveaways, and other subscriber-only resources you can’t get anywhere else. 

    I’m

    Seth Yakatan

    I’m a seasoned 30-year veteran of M&A and capital markets. I help entrepreneurs secure funding and successfully exit their business. To date, I’ve raised more than $1B and sold 22 companies. At this point, there’s no scenario I haven’t encountered.

    Looking to raise, merge or exit? LET'S TALK.

    Stop waiting. Start winning.

    Join our community of founders, executives and leaders looking to learn and level up.

    Connect With Seth

    You’ll get first dibs on events, podcasts, webinars, giveaways, and other subscriber-only resources you can’t get anywhere else.